SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001140361-08-008151
Filing Date
2008-03-31
Accepted
2008-03-31 15:49:51
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICAL INC 10KSB 12-31-2007 form10ksb.htm 10KSB 1228907
2 EXHIBIT 10.6 ex10_6.htm EX-10.6 127730
3 EXHIBIT 14 ex14.htm EX-14 32361
4 EXHIBIT 23 ex23.htm EX-23 2905
5 EXHIBIT 24 ex24.htm EX-24 24772
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 12831
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 12726
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 7514
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 7472
  Complete submission text file 0001140361-08-008151.txt   1458729
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-50590 | Film No.: 08724501
SIC: 2834 Pharmaceutical Preparations